TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Cell and Gene Therapy Manufacturing Services Market Landscape
4.1 Overview
4.2 Europe PEST Analysis
5. Europe Cell and Gene Therapy Manufacturing Services Market - Key Industry Dynamics
5.1 Key Market Drivers:
5.1.1 Increase in Number of Approval of Cell and Gene Therapies
5.1.2 Increasing Popularity of Outsourcing Cell and Gene Therapy Manufacturing
5.2 Market Restraints
5.2.1 High Cost of Cell and Gene Therapy Manufacturing
5.3 Market Opportunities
5.3.1 Strategic Initiatives by Companies
5.4 Future Trends
5.4.1 Automation of Cell and Gene Therapy Manufacturing Services
5.5 Impact Analysis:
6. Europe Cell and Gene Therapy Manufacturing Services Market - Europe Market Analysis
6.1 Europe Cell and Gene Therapy Market Revenue (US$ Mn), 2022 - 2030
7. Europe Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 - by Type
7.1 Overview
7.2 Europe Cell and Gene Therapy Manufacturing Services Market Revenue Share, by Type 2022 & 2030 (%)
7.3 Cell Therapy
7.3.1 Overview
7.3.2 Cell Therapy: Europe Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
7.3.2.1 Autologous
7.3.2.1.1 Overview
7.3.2.1.2 Autologous: Europe Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
7.3.2.2 Allogenic
7.3.2.2.1 Overview
7.3.2.2.2 Allogenic: Europe Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Gene Therapy
7.4.1 Overview
7.4.2 Gene Therapy: Europe Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
7.4.2.1 Viral Vector
7.4.2.1.1 Overview
7.4.2.1.2 Viral Vector: Europe Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
7.4.2.2 Non-Viral Vector
7.4.2.2.1 Overview
7.4.2.2.2 Non-Viral Vector: Europe Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
8. Europe Cell and Gene Therapy Manufacturing Services Market Analysis and Forecasts to 2030 - by Indication
8.1 Overview
8.2 Europe Cell and Gene Therapy Manufacturing Services Market, by Indication 2022 & 2030 (%)
8.3 Cancer
8.3.1 Overview
8.3.2 Cancer: Europe Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Orthopedics
8.4.1 Overview
8.4.2 Orthopedics: Europe Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Others
8.5.1 Overview
8.5.2 Others: Europe Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
9. Europe Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 - by Application
9.1 Overview
9.2 Europe Cell and Gene Therapy Manufacturing Services Market Revenue Share, by Application 2022 & 2030 (%)
9.4 Clinical Manufacturing
9.4.1 Overview
9.4.2 Clinical Manufacturing: Europe Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Commercial Manufacturing
9.5.1 Overview
9.5.2 Commercial Manufacturing: Europe Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
10. Europe Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 - by End User
10.1 Overview
10.2 Europe Cell and Gene Therapy Manufacturing Services Market Revenue Share, by End User 2022 & 2030 (%)
10.4 Pharmaceutical and Biotechnology Companies
10.4.1 Overview
10.4.2 Pharmaceutical & Biotechnology Companies: Europe Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
10.5 Contract Research Organizations (CROs)
10.5.1 Overview
10.5.2 Contract Research Organizations (CROs): Europe Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
11. Europe Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 - Country Analysis
11.1 Overview
11.1.1 Europe: Europe Cell and Gene Therapy Manufacturing Services Market, By Country, 2022 & 2030 (%)
11.1.1.1 Germany: Europe Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
11.1.1.1.1 Germany: Europe Cell and Gene Therapy Manufacturing Services Market, by Type, 2020-2030 (US$ Million)
11.1.1.1.1.1 Germany: Europe Cell and Gene Therapy Manufacturing Services Market, by Cell Therapy, 2020-2030 (US$ Million)
11.1.1.1.1.2 Germany: Europe Cell and Gene Therapy Manufacturing Services Market, by Gene Therapy, 2020-2030 (US$ Million)
11.1.1.1.2 Germany: Europe Cell and Gene Therapy Manufacturing Services Market, by Indication, 2020-2030 (US$ Million)
11.1.1.1.3 Germany: Europe Cell and Gene Therapy Manufacturing Services Market, by Application, 2020-2030 (US$ Million)
11.1.1.1.4 Germany: Europe Cell and Gene Therapy Manufacturing Services Market, by End User, 2020-2030 (US$ Million)
11.1.1.2 UK: Europe Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
11.1.1.2.1 UK: Europe Cell and Gene Therapy Manufacturing Services Market, by Type, 2020-2030 (US$ Million)
11.1.1.2.1.1 UK: Europe Cell and Gene Therapy Manufacturing Services Market, by Cell Therapy, 2020-2030 (US$ Million)
11.1.1.2.1.2 UK: Europe Cell and Gene Therapy Manufacturing Services Market, by Gene Therapy, 2020-2030 (US$ Million)
11.1.1.2.2 UK: Europe Cell and Gene Therapy Manufacturing Services Market, by Indication, 2020-2030 (US$ Million)
11.1.1.2.3 UK: Europe Cell and Gene Therapy Manufacturing Services Market, by Application, 2020-2030 (US$ Million)
11.1.1.2.4 UK: Europe Cell and Gene Therapy Manufacturing Services Market, by End User, 2020-2030 (US$ Million)
11.1.1.3 France: Europe Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
11.1.1.3.1 France: Europe Cell and Gene Therapy Manufacturing Services Market, by Type, 2020-2030 (US$ Million)
11.1.1.3.1.1 France: Europe Cell and Gene Therapy Manufacturing Services Market, by Cell Therapy, 2020-2030 (US$ Million)
11.1.1.3.1.2 France: Europe Cell and Gene Therapy Manufacturing Services Market, by Gene Therapy, 2020-2030 (US$ Million)
11.1.1.3.2 France: Europe Cell and Gene Therapy Manufacturing Services Market, by Indication, 2020-2030 (US$ Million)
11.1.1.3.3 France: Europe Cell and Gene Therapy Manufacturing Services Market, by Application, 2020-2030 (US$ Million)
11.1.1.3.4 France: Europe Cell and Gene Therapy Manufacturing Services Market, by End User, 2020-2030 (US$ Million)
11.1.1.4 Italy: Europe Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
11.1.1.4.1 Italy: Europe Cell and Gene Therapy Manufacturing Services Market, by Type, 2020-2030 (US$ Million)
11.1.1.4.1.1 Italy: Europe Cell and Gene Therapy Manufacturing Services Market, by Cell Therapy, 2020-2030 (US$ Million)
11.1.1.4.1.2 Italy: Europe Cell and Gene Therapy Manufacturing Services Market, by Gene Therapy, 2020-2030 (US$ Million)
11.1.1.4.2 Italy: Europe Cell and Gene Therapy Manufacturing Services Market, by Indication, 2020-2030 (US$ Million)
11.1.1.4.3 Italy: Europe Cell and Gene Therapy Manufacturing Services Market, by Application, 2020-2030 (US$ Million)
11.1.1.4.4 Italy: Europe Cell and Gene Therapy Manufacturing Services Market, by End User, 2020-2030 (US$ Million)
11.1.1.5 Spain: Europe Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
11.1.1.5.1 Spain: Europe Cell and Gene Therapy Manufacturing Services Market, by Type, 2020-2030 (US$ Million)
11.1.1.5.1.1 Spain: Europe Cell and Gene Therapy Manufacturing Services Market, by Cell Therapy, 2020-2030 (US$ Million)
11.1.1.5.1.2 Spain: Europe Cell and Gene Therapy Manufacturing Services Market, by Gene Therapy, 2020-2030 (US$ Million)
11.1.1.5.2 Spain: Europe Cell and Gene Therapy Manufacturing Services Market, by Indication, 2020-2030 (US$ Million)
11.1.1.5.3 Spain: Europe Cell and Gene Therapy Manufacturing Services Market, by Application, 2020-2030 (US$ Million)
11.1.1.5.4 Spain: Europe Cell and Gene Therapy Manufacturing Services Market, by End User, 2020-2030 (US$ Million)
11.1.1.6 Rest of Europe: Europe Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
11.1.1.6.1 Rest of Europe: Europe Cell and Gene Therapy Manufacturing Services Market, by Type, 2020-2030 (US$ Million)
11.1.1.6.1.1 Rest of Europe: Europe Cell and Gene Therapy Manufacturing Services Market, by Cell Therapy, 2020-2030 (US$ Million)
11.1.1.6.1.2 Rest of Europe: Europe Cell and Gene Therapy Manufacturing Services Market, by Gene Therapy, 2020-2030 (US$ Million)
11.1.1.6.2 Rest of Europe: Europe Cell and Gene Therapy Manufacturing Services Market, by Indication, 2020-2030 (US$ Million)
11.1.1.6.3 Rest of Europe: Europe Cell and Gene Therapy Manufacturing Services Market, by Application, 2020-2030 (US$ Million)
11.1.1.6.4 Rest of Europe: Europe Cell and Gene Therapy Manufacturing Services Market, by End User, 2020-2030 (US$ Million)
12. Europe Cell and Gene Therapy Manufacturing Services Market - Industry Landscape
12.1 Overview
12.2 Growth Strategies in Europe Cell and Gene Therapy Manufacturing Services Market
12.3 Organic Growth Strategies
12.3.1 Overview
12.4 Inorganic Growth Strategies
12.4.1 Overview
13. Company Profiles
13.1 Thermo Fisher Scientific Inc
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Merck KGaA
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Charles River Laboratories International Inc
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Lonza Group AG
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 WuXi AppTec Co Ltd
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Catalent Inc
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Takara Bio Inc
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Nikon Corp
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 FUJIFILM Holdings Corp
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Oxford BioMedica Plc
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments



List of Tables
Table 1. Europe Cell and Gene Therapy Market Segmentation
Table 2. Germany: Europe Cell and Gene Therapy Manufacturing Services Market, by Type, 2020-2030 (US$ Million)
Table 3. Germany: Europe Cell and Gene Therapy Manufacturing Services Market, by Cell Therapy, 2020-2030 (US$ Million)
Table 4. Germany: Europe Cell and Gene Therapy Manufacturing Services Market, by Gene Therapy, 2020-2030 (US$ Million)
Table 5. Germany: Europe Cell and Gene Therapy Manufacturing Services Market, by Indication, 2020-2030 (US$ Million)
Table 6. Germany: Europe Cell and Gene Therapy Manufacturing Services Market, by Application, 2020-2030 (US$ Million)
Table 7. Germany: Europe Cell and Gene Therapy Manufacturing Services Market, by End User, 2020-2030 (US$ Million)
Table 8. UK: Europe Cell and Gene Therapy Manufacturing Services Market, by Type, 2020-2030 (US$ Million)
Table 9. UK: Europe Cell and Gene Therapy Manufacturing Services Market, by Cell Therapy, 2020-2030 (US$ Million)
Table 10. UK: Europe Cell and Gene Therapy Manufacturing Services Market, by Gene Therapy, 2020-2030 (US$ Million)
Table 11. UK: Europe Cell and Gene Therapy Manufacturing Services Market, by Indication, 2020-2030 (US$ Million)
Table 12. UK: Europe Cell and Gene Therapy Manufacturing Services Market, by Application, 2020-2030 (US$ Million)
Table 13. UK: Europe Cell and Gene Therapy Manufacturing Services Market, by End User, 2020-2030 (US$ Million)
Table 14. France: Europe Cell and Gene Therapy Manufacturing Services Market, by Type, 2020-2030 (US$ Million)
Table 15. France: Europe Cell and Gene Therapy Manufacturing Services Market, by Cell Therapy, 2020-2030 (US$ Million)
Table 16. France: Europe Cell and Gene Therapy Manufacturing Services Market, by Gene Therapy, 2020-2030 (US$ Million)
Table 17. France: Europe Cell and Gene Therapy Manufacturing Services Market, by Indication, 2020-2030 (US$ Million)
Table 18. France: Europe Cell and Gene Therapy Manufacturing Services Market, by Application, 2020-2030 (US$ Million)
Table 19. France: Europe Cell and Gene Therapy Manufacturing Services Market, by End User, 2020-2030 (US$ Million)
Table 20. Italy: Europe Cell and Gene Therapy Manufacturing Services Market, by Type, 2020-2030 (US$ Million)
Table 21. Italy: Europe Cell and Gene Therapy Manufacturing Services Market, by Cell Therapy, 2020-2030 (US$ Million)
Table 22. Italy: Europe Cell and Gene Therapy Manufacturing Services Market, by Gene Therapy, 2020-2030 (US$ Million)
Table 23. Italy: Europe Cell and Gene Therapy Manufacturing Services Market, by Indication, 2020-2030 (US$ Million)
Table 24. Italy: Europe Cell and Gene Therapy Manufacturing Services Market, by Application, 2020-2030 (US$ Million)
Table 25. Italy: Europe Cell and Gene Therapy Manufacturing Services Market, by End User, 2020-2030 (US$ Million)
Table 26. Spain: Europe Cell and Gene Therapy Manufacturing Services Market, by Type, 2020-2030 (US$ Million)
Table 27. Spain: Europe Cell and Gene Therapy Manufacturing Services Market, by Cell Therapy, 2020-2030 (US$ Million)
Table 28. Spain: Europe Cell and Gene Therapy Manufacturing Services Market, by Gene Therapy, 2020-2030 (US$ Million)
Table 29. Spain: Europe Cell and Gene Therapy Manufacturing Services Market, by Indication, 2020-2030 (US$ Million)
Table 30. Spain: Europe Cell and Gene Therapy Manufacturing Services Market, by Application, 2020-2030 (US$ Million)
Table 31. Spain: Europe Cell and Gene Therapy Manufacturing Services Market, by End User, 2020-2030 (US$ Million)
Table 32. Rest of Europe: Europe Cell and Gene Therapy Manufacturing Services Market, by Type, 2020-2030 (US$ Million)
Table 33. Rest of Europe: Europe Cell and Gene Therapy Manufacturing Services Market, by Cell Therapy, 2020-2030 (US$ Million)
Table 34. Rest of Europe: Europe Cell and Gene Therapy Manufacturing Services Market, by Gene Therapy, 2020-2030 (US$ Million)
Table 35. Rest of Europe: Europe Cell and Gene Therapy Manufacturing Services Market, by Indication, 2020-2030 (US$ Million)
Table 36. Rest of Europe: Europe Cell and Gene Therapy Manufacturing Services Market, by Indication, 2020-2030 (US$ Million)
Table 37. Rest of Europe: Europe Cell and Gene Therapy Manufacturing Services Market, by End User, 2020-2030 (US$ Million)
Table 38. Recent Organic Growth Strategies in Europe Cell and Gene Therapy Manufacturing Services Market
Table 39. Recent Inorganic Growth Strategies in the Europe Cell and Gene Therapy Manufacturing Services Market

List of Figures
Figure 1. Europe Cell and Gene Therapy Market Segmentation, By Country
Figure 2. Europe PEST Analysis
Figure 3. Europe Cell and Gene Therapy Market - Key Industry Dynamics
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. Europe Cell and Gene Therapy Market Revenue (US$ Mn), 2022 - 2030
Figure 6. Europe Cell and Gene Therapy Manufacturing Services Market Revenue Share, by Type 2022 & 2030 (%)
Figure 7. Cell Therapy: Europe Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Autologous: Europe Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Allogenic: Europe Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Gene Therapy: Europe Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Viral Vector: Europe Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Non-Viral Vector: Europe Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Europe Cell and Gene Therapy Manufacturing Services Market, by Indication 2022 & 2030 (%)
Figure 14. Cancer: Europe Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Orthopedics: Europe Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Others: Europe Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Europe Cell and Gene Therapy Manufacturing Services Market Revenue Share, by Application 2022 & 2030 (%)
Figure 18. Clinical Manufacturing: Europe Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Commercial Manufacturing: Europe Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Europe Cell and Gene Therapy Manufacturing Services Market Revenue Share, by End User 2022 & 2030 (%)
Figure 21. Pharmaceutical & Biotechnology Companies: Europe Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Contract Research Organizations (CROs): Europe Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Europe: Cell and Gene Therapy Manufacturing Services Market, by Key Region - Revenue (2022) (US$ Million)
Figure 24. Europe: Europe Cell and Gene Therapy Manufacturing Services Market, By Country, 2022 & 2030 (%)
Figure 25. Germany: Europe Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
Figure 26. UK: Europe Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. France: Europe Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
Figure 28. Italy: Europe Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
Figure 29. Spain: Europe Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
Figure 30. Rest of Europe: Europe Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
Figure 31. Growth Strategies in Europe Cell and Gene Therapy Manufacturing Services Market